simvastatin and eye
simvastatin has been researched along with eye in 5 studies
Research
Studies (5)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Cigala, O; Della Valle, M; Malarbi, AL; Marasco, A; Pancallo, MT | 1 |
| Walker, JF | 1 |
| Hockwin, O; Paulus, U; Schmidt, J; Schmitt, C; von Bergmann, K | 1 |
| Liao, SL; Tang, WC; Wang, CC; Wang, SH; Wei, YH; Yang, CH | 1 |
Other Studies
5 other study(ies) available for simvastatin and eye
| Article | Year |
|---|---|
[Simvastatin in the treatment of hypercholesterolemia].
Topics: Aged; Anticholesteremic Agents; Blood Pressure; Cholesterol; Drug Evaluation; Eye; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lovastatin; Male; Middle Aged; Simvastatin; Triglycerides | 1991 |
Tolerability of simvastatin.
Topics: Anticholesteremic Agents; Eye; Humans; Liver; Lovastatin; Muscles; Simvastatin | 1989 |
Simvastatin: the clinical profile.
Topics: Aged; Creatine Kinase; Drug Therapy, Combination; Eye; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperlipoproteinemia Type II; Liver; Lovastatin; Male; Middle Aged; Simvastatin; Transaminases | 1989 |
Ocular drug safety and HMG-CoA-reductase inhibitors.
Topics: Color Perception; Contrast Sensitivity; Eye; Female; Fenofibrate; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Intraocular Pressure; Lens, Crystalline; Lovastatin; Male; Middle Aged; Photography; Refraction, Ocular; Safety; Simvastatin; Visual Acuity | 1994 |
Simvastatin Inhibits CYR61 Expression in Orbital Fibroblasts in Graves' Ophthalmopathy through the Regulation of FoxO3a Signaling.
Topics: Adult; Chemokine CCL20; Cysteine-Rich Protein 61; Eye; Female; Fibroblasts; Forkhead Box Protein O3; Gene Expression Regulation; Graves Ophthalmopathy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Interleukin-6; Male; Middle Aged; Signal Transduction; Simvastatin | 2021 |